This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
1cP-LSD: Difference between revisions
>Graham m wiki ref formatting |
>Thomasdequincey →Legal status: . Added a section for Canada and rearranged the list to be in alphabetical order. |
||
| Line 168: | Line 168: | ||
===Dependence and abuse potential=== | ===Dependence and abuse potential=== | ||
Although no formal studies have been conducted, it is assumed that like LSD itself, 1cP-LSD is [[Addiction potential::non-addictive with a low abuse potential]]. There are no literature reports of successful attempts to train animals to self-administer LSD — an animal model predictive of abuse liability — indicating that it does not have the necessary pharmacology to either initiate or maintain dependence.<ref name="Nichols2004"/> Likewise, there is virtually no withdrawal syndrome when chronic use of LSD is stopped.{{citation needed}} It is likely that 1cP-LSD does not deviate from LSD in this respect. | Although no formal studies have been conducted, it is assumed that like LSD itself, 1cP-LSD is [[Addiction potential::non-addictive with a low abuse potential]]. There are no literature reports of successful attempts to train animals to self-administer LSD — an animal model predictive of abuse liability — indicating that it does not have the necessary pharmacology to either initiate or maintain dependence.<ref name="Nichols2004" /> Likewise, there is virtually no withdrawal syndrome when chronic use of LSD is stopped.{{citation needed}} It is likely that 1cP-LSD does not deviate from LSD in this respect. | ||
Tolerance to the effects of 1cP-LSD is built [[Time to full tolerance::almost immediately after ingestion]]. After that, it takes about [[Time to half tolerance::5-7 days]] for the tolerance to be reduced to half and [[Time to zero tolerance::14 days]] to be back at baseline (in the absence of further consumption). 1cP-LSD produces cross-tolerance with [[Cross-tolerance::all [[psychedelic]]s]], meaning that after the use of 1cP-LSD they will have a reduced effect. | Tolerance to the effects of 1cP-LSD is built [[Time to full tolerance::almost immediately after ingestion]]. After that, it takes about [[Time to half tolerance::5-7 days]] for the tolerance to be reduced to half and [[Time to zero tolerance::14 days]] to be back at baseline (in the absence of further consumption). 1cP-LSD produces cross-tolerance with [[Cross-tolerance::all [[psychedelic]]s]], meaning that after the use of 1cP-LSD they will have a reduced effect. | ||
| Line 181: | Line 181: | ||
{{LegalStub}} | {{LegalStub}} | ||
*'''Canada''': 1cP- LSD is unscheduled in Canada. | |||
*'''Czech Republic''': 1cP-LSD is not a controlled substance, and is not named on the list of illegal substances.<ref>{{cite web | url=https://www.zakonyprolidi.cz/cs/2013-463 | title=Nařízení vlády č. 463/2013 Sb. Nařízení vlády o seznamech návykových látek | publisher=Zákony pro lidi | language=Czech|id=178/2013|date=December 18, 2013}}</ref> | |||
*'''Germany''': 1cP-LSD is controlled under the NpSG (''New Psychoactive Substances Act'')<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/anlage.html|title=Anlage NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz [Federal Ministry of Justice and Consumer Protection]|access-date=September 16, 2021|language=de}}</ref> as of July 2, 2021.<ref>{{Cite web|access-date=September 16, 2021|language=de|pages=2231–2243|publication-date=July 2, 2021|publisher=Bundesanzeiger Verlag|title=Zweite Verordnung zur Änderung der Anlage des Neue-psychoaktive-Stoffe-Gesetzes|url=https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl121s2231.pdf|work=Bundesgesetzblatt Jahrgang 2021 Teil I Nr. 38}}</ref> Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/__4.html|title=§ 4 NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz [Federal Ministry of Justice and Consumer Protection]|access-date=September 16, 2021|language=de}}</ref> | *'''Germany''': 1cP-LSD is controlled under the NpSG (''New Psychoactive Substances Act'')<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/anlage.html|title=Anlage NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz [Federal Ministry of Justice and Consumer Protection]|access-date=September 16, 2021|language=de}}</ref> as of July 2, 2021.<ref>{{Cite web|access-date=September 16, 2021|language=de|pages=2231–2243|publication-date=July 2, 2021|publisher=Bundesanzeiger Verlag|title=Zweite Verordnung zur Änderung der Anlage des Neue-psychoaktive-Stoffe-Gesetzes|url=https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl121s2231.pdf|work=Bundesgesetzblatt Jahrgang 2021 Teil I Nr. 38}}</ref> Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/__4.html|title=§ 4 NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz [Federal Ministry of Justice and Consumer Protection]|access-date=September 16, 2021|language=de}}</ref> | ||
*'''Japan''': 1cP-LSD is controlled by the Pharmaceutical Affairs Law in Japan, making it illegal to possess or sell.<ref>{{cite web|title=指定薬物を指定する省令が公布されました|language=ja|url=https://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/iyakuhin/yakubuturanyou/oshirase/20210122-1.html|publisher=厚生労働省 [Ministry of Health, Labour and Welfare (MHLW)]|access-date=March 25, 2021}}</ref> | *'''Japan''': 1cP-LSD is controlled by the Pharmaceutical Affairs Law in Japan, making it illegal to possess or sell.<ref>{{cite web|title=指定薬物を指定する省令が公布されました|language=ja|url=https://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/iyakuhin/yakubuturanyou/oshirase/20210122-1.html|publisher=厚生労働省 [Ministry of Health, Labour and Welfare (MHLW)]|access-date=March 25, 2021}}</ref> | ||
*'''Sweden''': Sweden's public health agency suggested classifying 1cP-LSD as a dangerous substance on December 18, 2019.<ref>{{cite web|url=https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2019/december/tjugotre-amnen-foreslas-klassas-som-narkotika-eller-halsofarlig-vara/|title=Tjugotre ämnen föreslås klassas som narkotika eller hälsofarlig vara | trans-title = Twenty-three substances are proposed to be classified as drugs or dangerous goods |publisher=Folkhälsomyndigheten [Public Health Agency of Sweden]|language=sv|date=December 18, 2019|access-date=July 14, 2020}}</ref> | *'''Sweden''': Sweden's public health agency suggested classifying 1cP-LSD as a dangerous substance on December 18, 2019.<ref>{{cite web|url=https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2019/december/tjugotre-amnen-foreslas-klassas-som-narkotika-eller-halsofarlig-vara/|title=Tjugotre ämnen föreslås klassas som narkotika eller hälsofarlig vara | trans-title = Twenty-three substances are proposed to be classified as drugs or dangerous goods |publisher=Folkhälsomyndigheten [Public Health Agency of Sweden]|language=sv|date=December 18, 2019|access-date=July 14, 2020}}</ref> | ||